The global AI in drug discovery market is experiencing robust expansion, fueled by the escalating demand for innovative drug therapies and the expanding manufacturing capabilities within the life sciences sector. AI technologies, including machine learning and deep learning, are being increasingly applied across various stages of drug discovery, from initial compound screening to predicting success rates in clinical trials. This integration is crucial for identifying novel drug targets and optimizing potential candidates. The market’s growth is further propelled by substantial investments, funding initiatives, and the emergence of numerous startups dedicated…